Search
for
Sort by
Research 181–210 of 1000+
- Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women
- Androgen treatment of postmenopausal women
- Effective medical treatment for common baldness in women
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Side effects of common acne treatments
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
- INDIVIDUALIZED TREATMENT OF POLYCYSTIC OVARY SYNDROME: A MANIFESTATION-GUIDED PRACTICAL APPROACH
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Androgen treatment in women
- Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Common urologic diseases in older men and their treatment: how they impact fertility
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments
- The Effect of Parathyroid Hormones on Hair Follicle Physiology: Implications for Treatment of Chemotherapy-Induced Alopecia
- Cyclophosphamide: As bad as its reputation? Long-term single centre experience of cyclophosphamide side effects in the treatment of systemic autoimmune diseases
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Polycystic ovary syndrome: Pathophysiology, Symptoms, Risk factors, and Pharmacological treatment
- Therapeutic Androgen Receptor Ligands
- Auswirkungen einer Hormonersatztherapie mit Testosteron auf Haut, Haare und Anhangsgebilde
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Association of Surgical Risk With Exogenous Hormone Use in Transgender Patients
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review